Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Cannabis product manufacturer The Valens Company Inc. (TSX:VLNS) (OTCQX: VLNCF) entered a two-year agreement with Harvest One Cannabis Inc. (OTCQB: HRVOF) to produce and distribute the cannabis-infused topical brand LivRelief.
Harvest One, a cannabis-focused CPG company rolled out its first cannabis-infused portfolio of LivRelief products last year. Since then, the product line has advanced significantly, becoming the number one selling cannabis-infused topical brand in Ontario.
LivRelief is a line of cannabis-infused topical creams made of natural ingredients
containing a proprietary transdermal delivery system, which enables cannabinoids to penetrate desired areas. Creams from the line are accessible in three formats – 1) CBD only with 250mg of CBD, 2) 1:1 with 125mg of THC and 125mg of CBD, and 3) Extra strength CBD with 750mg CBD.
All these formats are about to be manufactured and distributed across Canada by Valens, with first shipments from its facilities expected at the beginning of the fiscal fourth quarter.
At the moment, the line is reachable across the nation via the Medical Cannabis by Shoppers marketplace and through some private retailers.
"The LivRelief cannabis-infused topical brand has established itself as a premium and reliable provider of cannabis-infused topicals with a leading-edge proprietary transdermal delivery system that took years of research, innovation, and dedication to develop," Tyler Robson, CEO, co-founder and chair of Valens stated. "We are proud to manufacture these top-selling creams in partnership with Harvest One and provide both new and experienced consumers the comfort to engage with cannabis-infused topicals. Valens already manufactures the number one selling bath product in Ontario3 and now adds the number one selling cannabis-infused topical brand to its portfolio, making it a clear leader in both the topicals and health and wellness verticals in Canada."
Gord Davey, president and CEO of Harvest One added they are thrilled to team up with the Valens Company. "Our partnership with The Valens Company will accelerate national and global growth opportunities,” Davey said.
Price Action
The Valens Company’s shares were trading 7.52% at $2.05 per share at the time of writing Wednesday midday.
Photo: Courtesy of Shane Rounce on Unsplash